Critical Congenital Heart Disease Screening Saving Lives One Infant at a Time Christina Rust, MSN, RN.

Slides:



Advertisements
Similar presentations
Cyanotic Congenital Heart Disease
Advertisements

Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Potential Impact of CCHD Screening Peterson C, Ailes E, Riehle-Colarusso T, et al.
Diagnosis and Early Management of the Infant with Suspected Congenital Heart Disease.
Congenital Heart Disease Cheston M. Berlin, Jr., M.D. Department of Pediatrics.
Congenital Heart Defects Fred Hill, MA, RRT. Categories of Heart Defects Left-to-right shunt Cyanotic heart defects Obstructive heart defects.
Congenital Heart Disease in Neonates EGM Hoosen Paediatric Cardiology Inkosi Albert Luthuli Central Hospital.
Newborn Screening for Critical Congenital Heart Diseases (CCHD) Lazaros Kochilas, MD Associate Professor of Pediatrics University of Minnesota.
Invasive test results CHD Astraia-search CHD Q-diagnoses CHD* * CHD=structural congenital heart disease ** Right aortic arch, persistent arterial duct.
Health and Wellness for all Arizonans Arizona Birth Defects Monitoring Program (ABDMP)
Newborn Screening for Critical Congenital Heart Disease
Screening for Critical Congenital Heart Disease using Pulse Oximetry Legislative Advocacy Anoop Rao PGY2, Pediatrics Image
Cyanotic congenital heart disease Case Presentation Term male infant delivered by spontaneous vaginal delivery and appears cyanotic at birth respiratory.
Congenital Heart Disease
Congenital Heart Disease Seth Malin, MD Bronson Methodist Hospital MSU KCMS, College of Human Medicine.
A Quick Tour of Congenital Heart Disease
Genetics and Biomarkers in Congenital Heart Disease SSA Conference, November 9, 2010 Allen D. Everett, MD Associate Professor, Pediatric Cardiology Helen.
HOW TO DEAL WITH A NEWBORN BABY WITH CONGENITAL HEART DISEASE ?
DR. HANA OMER CONGENITAL HEART DEFECTS. The major development of the fetal heart occurs between the fourth and seventh weeks of gestation, and most congenital.
Chrissy Russell Liz McIe.  A defect in the structure of the heart and great vessels which is present at birth.  Abnormal heart development.
Congenital Heart Defects
Pulse oximetry screening for congenital heart disease. Does it work? Is it worth it?
Newborn Screening for Critical Congenital Heart Defects by Pulse Oximetry Fall CME Course 2012 Robert Jansen, MD St. Vincent Women’s Hospital.
Cyanotic Heart Disease Nidhi Ravishankar Role number: 1440.
Congenital Heart Lesions. Outline Normal anatomy L -> R shunt Left side obstruction Cyanotic heart lesions Right side obstruction and R -> L shunt Transposition.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 40 Nursing Care of the Child with a Cardiovascular Disorder.
Principal Groups of CHD
CONGENITAL DISEASES Dr. Meg-angela Christi Amores.
2014 Summit Co-Convener:Founder: Patient Safety Science & Technology Summit 2014.
Congenital Heart Disease Emad Al Khatib, RN,MSN,CNS.
Duchenne Muscular Dystrophy: Cardiac Management. Introduction Aim: early detection and treatment of deterioration in heart muscle function Cardiac disease.
INTRODUCTION The Normal Heart has four chambers. Consisting of the 2 basic circulation; The pulmonary circulation carrying the deoxygenated blood and.
INTRODUCTION A 35 year old woman with transposition of the great arteries repaired with a Mustard procedure attends your clinic for annual follow-up. Her.
Pulse Oximetry screening for Cardiac malformations in the neonate Majd Abu-Harb September 2014.
Bob Bowman, MS Director of Genomics & Newborn Screening Indiana State Department of Health.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 40 Nursing Care of the Child With a Cardiovascular Disorder Maternity and.
Congenital Heart Disease in Children Dr. Sara Mitchell January
CYANOTIC CONGENITAL HEART DISEASE
Vanessa Beretta & Dan Fleming. About CHD A congenital heart defect also known as CHD is a defect in the structure of the heart and great vessels. Most.
Congenital Heart Disease Most occur during weeks 3 to 8 Incidence 6 to 8 per 1,000 live born births Some genetic – Trisomies 13, 15, 18, & 21 and Turner.
Congenital Heart Lesions
© The Children's Mercy Hospital, /14 Critical Congenital Heart Disease (CCHD) Meagan Dorton, MSN, MBA, RN-CPN Pulse Oximetry Screening for Detecting.
CONGENITAL HEART DEFECTS DR. HANA OMER. CONGENITAL HEART DEFECTS D. HANA OMER.
DR AFTAB YUNUS FRCSEd. CHAIRMAN CARDIAC SURGERY
Lecture II Congenital Heart Diseases Dr. Aya M. Serry 2015/2016.
CONGENITAL HEART DISEASES
Transposition of the Great Arteries. What is TGA 1.Congenital heart defect 2.Large blood vessels that carry blood from the heart to the lungs are improperly.
Hypoplastic Left Heart Syndrome By: Tyler Nickels, Amanda McKellar, Kassie Herp, Zachary Zwiernikowski, & Amanda Mathy.
PATHOPHYSIOLOGY OF CYANOTIC CHD
Dr David Roden Neonatologist Staffordshire, Shropshire and Black Country Newborn Network.
Pulse Oximetry Screening for Critical Congenital Heart Disease (CCHD): The Wisconsin Experience Region IV Genetics Meeting September 11, 2012 Sharon Fleischfresser.
Why? 1 in 100 newborns have congenital heart defects 25% of all CHD are critical (CCHD) requiring intervention in the.
Congenital Heart Diseases Dr. Usha Singh Department of Pediatrics.
Congenital Heart Disease
Telephonic survey of the use of pulse oximetry as part of routine baby checks S Goyal, S Sen.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Post-Operative Outcomes in Children With and Without.
Recognition of Congenital Heart Disease Prenatal and newborn M. Beth Goens, MD Pediatric Cardiology University of New Mexico.
Congenital Heart Disease
Neonatal Cardiac assessment
Heart - Pathophysiology
Lorraine Freed Garg, MD, MPH Consultant in Public Health
Congenital Heart Disease
Congenital Heart Diseases
Newborn Screening: Achieving Timeliness
Purpose Infective endocarditis (IE) which is an uncommon disease in pediatric patients can cause significant morbidity and mortality. IE is treated with.
CYANOTIC CONGENITAL HEART DISEASE
Levine RA, DO. Miladinovic B, PhD. Nardell K, MD. Galas J, MD
Reduction in Infant Cardiac Deaths in US States Implementing Policies to Screen Newborns for Critical Congenital Heart Disease Matthew Oster, MD, MPH Washington,
Gerard R. Martin, MD Medical Director, Global Services
Michael J. Wolf, MD, Nikhil K. Chanani, MD, Micheal L
Congenital Heart Disease & Hemiparesis
Presentation transcript:

Critical Congenital Heart Disease Screening Saving Lives One Infant at a Time Christina Rust, MSN, RN

Heart disease caused by heart defects Due to structural malformation of the heart that forms in the early stages of cardiac development Normal flow of blood through the heart is disrupted Most common birth defect Congenital Heart Disease (CHD)

Affects 8 in every 1,000 live births Approximately 40,000 U.S. births/ year Leading cause of infant death in the developing world Screening provides significant opportunity to reduce infant mortality and morbidity (MMWR, 2013)

Heart disease caused by 7 types of cyanotic heart defects Can be fatal in infants if not detected and treated early Newborn physical assessment does not always identify CCHD – 41,494 deaths related to CCHD Over 50% of deaths were infants < 12 months of age (CDC, 2011) Critical Congenital Heart Defects (CCHD)

7 Critical Congenital Heart Defects (CCHD) Hypoplastic Left Heart Syndrome (HLHS) Tetrology of Fallot Truncus Arteriosis (TA) Transposition of the Great Arteries (TGA) Pulmonary Atresia Tricuspid Atresia Total Anomalous Pulmonary Venous Return (TAPVR)

Screening Tool for CCHD Simple, painless, non-invasive pulse oximetry application Estimates percent of hemoglobin in the blood that is saturated with oxygen Pulse oximetry reading taken on the right hand and one foot Reading values compared to standardized algorithm (AAP and AHA)

Follow-up for CCHD Infants with positive screen transferred to NICU Placed on ECG monitoring Assessed by NNP/Neonatologist Echocardiogram completed Consultation with local children’s hospial Pediatric cardiologist

Tracking Birth Defects No federal population based system to track CCHD in children and adults States track birth defects through birth records data systems CDC received a grant in 2012 to establish a congenital heart disease defects database in the U.S. Currently trialing in Massachusetts, New York, and Atlanta, Ga.

CCHD Prevention Prevention research requires creation of a national database of data - Geographic - Demographic - Genetic - Environmental - Other factors